Wockhardt Limited (NSE:WOCKPHARMA)
2,011.10
+21.90 (1.10%)
Jun 19, 2026, 3:30 PM IST
Wockhardt Market Cap
Wockhardt has a market cap or net worth of 326.79 billion as of June 18, 2026. Its market cap has increased by 37.25% in one year.
Market Cap
326.79B
Enterprise Value
345.40B
Revenue
33.73B
Ranking
n/a
PE Ratio
153.52
Stock Price
2,011.10
Market Cap Chart
Since February 21, 2001, Wockhardt's market cap has increased from 17.40B to 326.79B, an increase of 1,777.68%. That is a compound annual growth rate of 12.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 326.79B | 39.06% |
| Dec 31, 2025 | 235.00B | 2.08% |
| Dec 31, 2024 | 230.20B | 276.45% |
| Dec 29, 2023 | 61.15B | 90.30% |
| Dec 30, 2022 | 32.13B | -29.77% |
| Dec 31, 2021 | 45.75B | -24.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alkem Laboratories | 642.48B |
| Glenmark Pharmaceuticals | 624.68B |
| Ipca Laboratories | 402.32B |
| Ajanta Pharma | 382.81B |
| Gland Pharma | 362.30B |
| Emcure Pharmaceuticals | 336.71B |
| Piramal Pharma | 211.00B |
| Eris Lifesciences | 200.70B |